The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Investors understand that their principal will be at very high risk
Category
Sector Funds
Launch Date
06-Feb-24
ISIN Code
INF03VN01878
Scheme Benchmark
S&P BSE HEALTH CARE - TRI
AUM ( in Cr.)
108.61
portfolio price to book value
7.63
investing style?
Large Growth
fund manager?
Ramesh Mantri,Piyush Baranwal
inception date (regular plan)
expense ratio (regular plan) %
2.35